ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,698, issued on April 15, was assigned to VeroScience LLC (Tiverton, R.I.).
"Bromocriptine formulations" was invented by Anthony H. Cincotta (Tiverton, R.I.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure describes pharmaceutical formulations of bromocriptine and method of manufacturing and using such formulations. The formulations are useful for treating physiological disorders including improving glycemic control in the treatment of type 2 diabetes. Also disclosed is synthesis of bromocriptine citrate, and compositions and dosage forms containing bromocriptine citrate."
The patent was filed on June 14, 2023, under Application ...